RUBRA MEDICAMENTS LTD. - 531099 - Compliance Certificate Under Regulation 7(3)
Compliance Certificate under regulation 7(3)13-10-2020
13-10-2020
RUBRA MEDICAMENTS LTD. - 531099 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Abha KapoorDesignation :- Chief Financial Officer07-10-2020
RUBRA MEDICAMENTS LTD. - 531099 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Rubra Medicaments Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here01-10-2020
RUBRA MEDICAMENTS LTD. - 531099 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer Report01-10-2020
RUBRA MEDICAMENTS LTD. - 531099 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of AGM01-10-2020
RUBRA MEDICAMENTS LTD. - 531099 - Appointment of Company Secretary and Compliance Officer
Appointment of Ms. Ritu Chhatani as Company Secretary and Compliance Officer24-09-2020
RUBRA MEDICAMENTS LTD. - 531099 - Appointment of Company Secretary and Compliance Officer
Appointment of Ms. Ritu Chhatani as the Company Secretary and Compliance Officer of the Company21-09-2020
RUBRA MEDICAMENTS LTD. - 531099 - Announcement under Regulation 30 (LODR)-Cessation
Resignation of Mr. Manish Gandhi from the post of Director of the Company with effect from September 12, 202012-09-2020
RUBRA MEDICAMENTS LTD. - 531099 - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2020
Rubra Medicaments Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2020, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 010-09-2020
RUBRA MEDICAMENTS LTD. - 531099 - Fixes Book Closure for AGM (Cut-off date for e-voting)
Rubra Medicaments Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2020 to September 26, 2020 (both days inclusive) for the purpose of 29th Annual General Meeting (AGM) of the Company to be held on September 30, 2020.08-09-2020